Human monoclonal immunoglobulin M antibodies to ganglioside GM(1) show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barre syndrome

MARTINA PRENDERGAST

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

Abstract

We examined the reactivity of a panel of anti-GM(1) immunoglobulin M monoclonal antibodies (MAbs) cloned from multifocal motor neuropathy patients with lipopolysaccharides (LPSs) of Campylobacter jejuni strains, including serotype O:41 strains associated with Guillain-Barre syndrome. The MAbs reacted with ganglioside GM(1) to different degrees, and these differences in fine specificities for GM(!) were reflected in the different degrees of reactivity with each of the C. jejuni LPSs tested. Antibodies could also be discriminated by the varying patterns of inhibition by cholera toxin (a GM(1) ligand) in LPS binding studies. These results indicate that there is a substantial heterogeneity among C. jejuni O:41 strains in their expression of GM(1)-like epitopes and among the fine specificities of different neuropathy-associated anti-GM(1) antibodies.
Original languageEnglish (Ireland)
Number of pages4
JournalInfection And Immunity
Volume67
Publication statusPublished - 1 Jul 1999

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • Prendergast, MM,Willison, HJ,Moran, AP

Fingerprint

Dive into the research topics of 'Human monoclonal immunoglobulin M antibodies to ganglioside GM(1) show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barre syndrome'. Together they form a unique fingerprint.

Cite this